NaCl Nanoparticles as a Cancer Therapeutic

Area of Science:

• Nanomedicine
• Cancer Biology
• Immunology

Background:

• Inorganic nanoparticles are widely studied, but common electrolytes like NaCl are overlooked.
• Existing research assumes electrolyte nanoparticles rapidly dissolve and behave like their constituent salts.

Purpose of the Study:

• To challenge the assumption that electrolyte nanoparticles behave identically to dissolved salts.
• To investigate the therapeutic potential of sodium chloride nanoparticles (SCNPs) against cancer cells.

Main Methods:

• Preparation and characterization of sodium chloride nanoparticles (SCNPs).
• In vitro studies on cancer cell lines and normal cells to assess toxicity and cellular uptake.
• In vivo studies to evaluate therapeutic efficacy and immune response.

Main Results:

• SCNPs exhibit significant toxicity to cancer cells, inducing rapid cell lysis via endocytosis and osmotic shock.
• Normal cells show higher resistance to SCNPs due to lower intracellular sodium levels.
• SCNPs induce immunogenic cell death (ICD) and stimulate an anticancer immune response in vivo.

Conclusions:

• SCNPs represent a novel class of nanoparticle therapeutics distinct from their dissolved counterparts.
• SCNPs offer a dual mechanism of action: direct cancer cell killing and immune system activation.
• This research opens new avenues for nanoparticle-based cancer treatment strategies.